Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Study identifies factors associated with death in critically ill COVID-19 patients

Study identifies factors associated with death in critically ill COVID-19 patients

Doping agent Epo could be effective against Covid-19

Doping agent Epo could be effective against Covid-19

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Research reveals key role of fat cells in renal failure-associated cardiomyopathy

Research reveals key role of fat cells in renal failure-associated cardiomyopathy

Study finds more effective treatment for children with sickle cell anemia

Study finds more effective treatment for children with sickle cell anemia

Anticardiolipin antibodies and COVID-19

Anticardiolipin antibodies and COVID-19

Identifying key predictors of mortality in young dialysis patients

Identifying key predictors of mortality in young dialysis patients

Research highlights nutritional risks among female athletes

Research highlights nutritional risks among female athletes

COVID-19 produces lung inflammation in non-human primate experiments

COVID-19 produces lung inflammation in non-human primate experiments

Study reveals biochemical alterations in patients with Lesch-Nyhan disease

Study reveals biochemical alterations in patients with Lesch-Nyhan disease

Researchers treat TMC1-related deafness with gene therapy

Researchers treat TMC1-related deafness with gene therapy

Ruxolitinib shows promise in severe COVID-19

Ruxolitinib shows promise in severe COVID-19

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Common assumptions about mercury exposure should be reexamined, show studies

Common assumptions about mercury exposure should be reexamined, show studies

Clinical study shows promising results for treatment of VHL disease-associated renal tumors

Clinical study shows promising results for treatment of VHL disease-associated renal tumors

Researchers receive $5 million to study two types of parasitic infection

Researchers receive $5 million to study two types of parasitic infection

Kawasaki disease outbreak in children with COVID-19

Kawasaki disease outbreak in children with COVID-19

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Innovative device could help treat babies with blood disorders

Innovative device could help treat babies with blood disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.